Your browser doesn't support javascript.
loading
Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment.
Alhowail, Ahmad H; Eggert, Matthew; Bloemer, Jenna; Pinky, Priyanka D; Woodie, Lauren; Bhattacharya, Subhrajit; Bhattacharya, Dwipayan; Buabeid, Manal A; Smith, Bruce; Dhanasekaran, Muralikrishnan; Piazza, Gary; Reed, Miranda N; Escobar, Martha; Arnold, Robert D; Suppiramaniam, Vishnu.
Afiliação
  • Alhowail AH; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Eggert M; Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Kingdom of Saudi Arabia.
  • Bloemer J; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Pinky PD; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Woodie L; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Bhattacharya S; Department of Nutrition, Dietetics and Hospitality Management, College of Human Sciences, Auburn University, Auburn, AL, United States of America.
  • Bhattacharya D; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Buabeid MA; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Smith B; College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE.
  • Dhanasekaran M; Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States of America.
  • Piazza G; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Reed MN; Center for Neuroscience Initiative, Auburn University, Auburn, AL, United States of America.
  • Escobar M; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Arnold RD; Department of Drug Discovery and Development, Auburn University, Auburn, AL, United States of America.
  • Suppiramaniam V; Center for Neuroscience Initiative, Auburn University, Auburn, AL, United States of America.
PLoS One ; 18(11): e0294280, 2023.
Article em En | MEDLINE | ID: mdl-37948406
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Potenciação de Longa Duração / Disfunção Cognitiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Potenciação de Longa Duração / Disfunção Cognitiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article